Publication: FDA’s Contradictory Decisions Related to the Delaney Clause
Open/View Files
Date
2011
Authors
Published Version
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Katheryn Klimko, FDA’s Contradictory Decisions Related to the Delaney Clause (May 2011).
Research Data
Abstract
This paper will focus on FDA regulation under the Delaney Clause, and particularly regulations that have led to contradictory results. It first will examine the history and basic requirements of the Delaney Clause. It next will discuss cancer: statistics regarding the frequency, types, and causes of cancer. Then it will examine some foods and food additives that have been associated with some level of carcinogenicity and how FDA has handled them. It will conclude by discussing the inherent problems that the Delaney Clause presents in establishing a uniform system of regulation and, finally, by proposing some potential alternative ways in which FDA might better use its power to help the public avoid excessive exposure to carcinogenic food substances.
Description
Other Available Sources
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service